Bicarbonate

Bicarbonate

SCHEMBL485873

O=C(NC1CCCC1)c1cc(Cl)c2ccccc2c1OCc1ccc(C(F)(F)F)cc1F.O=C(O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.49
CRHR1 P34998 9/20 0.45
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
PTGDR Q13258 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485738 0.98 MRGPRX4 (0.51) MRGPRX4CRHR1MAPTLMNAPOLB
Formic Acid SCHEMBL27693419 0.94 MRGPRX4 (0.49) MRGPRX4CRHR1MAPTLMNAPOLB
SCHEMBL485934 0.86 CXCR2 (0.47) MRGPRX4CRHR1MAPTLMNAPOLB
SCHEMBL485710 0.86 MRGPRX4 (0.56) MRGPRX4CRHR1KMT2A
Formic Acid SCHEMBL27693450 0.85 MRGPRX4 (0.49) MRGPRX4CRHR1MAPTLMNAPOLB
SCHEMBL485567 0.84 CXCR2 (0.47) MRGPRX4CRHR1MAPTLMNAPOLB
SCHEMBL486088 0.84 MRGPRX4 (0.56) MRGPRX4CRHR1KMT2A
Formic Acid SCHEMBL27712986 0.83 GRM5 (0.42) MRGPRX4NPC1RAB9ASMN1; SMN2GAA
Formic Acid SCHEMBL27693233 0.83 CXCR2 (0.44) MRGPRX4CRHR1MAPTLMNAPOLB
SCHEMBL485826 0.82 MRGPRX4 (0.51) MRGPRX4CRHR1MAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836158-B1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION SANOFI AVENTIS DEUTSCHLAND (DE) 2012-02-01 EP claimed